Answers are grounded in this paper and cite their sources.
Reports catastrophic, near-fatal postoperative bleeding following single-dose parenteral ketorolac administration, highlighting risks when the drug is contraindicated.
Ketorolac is a nonsteroidal antiinflammatory drug that has been used as a postoperative analgesic since its introduction in the US in 1990. Although hemorrhagic side effects secondary to its use have been consistently described in the medical literature, its attendant complications have been commonly unappreciated by the medical profession. Two catastrophic, near-fatal, hemorrhagic postoperative events are described in which the use of ketorolac was unquestionably contraindicated.
No takes yet. Share an insight, caveat, or question.
Basil M. RuDusky (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: